Search

Your search keyword '"Nativel, B"' showing total 34 results

Search Constraints

Start Over You searched for: Author "Nativel, B" Remove constraint Author: "Nativel, B"
34 results on '"Nativel, B"'

Search Results

3. Mise en place d&8217;une surveillance spatialisée des malformations congénitales à La Réunion : choix méthodologiques

6. The South Pacific epidemic strain of Zika virus replicates efficiently in human epithelial A549 cells leading to IFN-beta production and apoptosis induction

7. French Intensive Care Society, International congress - Réanimation 2016

8. French Intensive Care Society, International congress – Réanimation 2016

9. Prenatal and neonatal phenotype of Larsen of La Réunion Island syndrome (B4GALT7-linkeropathy).

10. Maternal age and the prevalence of congenital heart defects in Europe, 1995-2015: A register-based study.

11. Prevalence of congenital heart defects in Europe, 2008-2015: A registry-based study.

12. The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors.

13. Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk.

14. Lack of Neuroprotective Effects of High-Density Lipoprotein Therapy in Stroke under Acute Hyperglycemic Conditions.

15. PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Hyperglycemic Mice Increases the Risk of Hemorrhagic Transformation of Ischemic Stroke.

16. Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells function.

17. PCSK9 levels do not predict severity and recurrence of cardiovascular events in patients with acute myocardial infarction.

18. Discordant malformations in monochorionic twins: a retrospective cohort study in La Reunion Island.

19. A small molecule inhibitor of PCSK9 that antagonizes LDL receptor binding via interaction with a cryptic PCSK9 binding groove.

20. Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes.

21. CD93 is a cell surface lectin receptor involved in the control of the inflammatory response stimulated by exogenous DNA.

23. PCSK9: from biology to clinical applications.

24. Subversion of the Heme Oxygenase-1 Antiviral Activity by Zika Virus.

25. PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate.

26. Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study.

27. A hemorrhagic transformation model of mechanical stroke therapy with acute hyperglycemia in mice.

28. Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab.

29. Porphyromonas gingivalis lipopolysaccharides act exclusively through TLR4 with a resilience between mouse and human.

30. ClearColi BL21(DE3)-based expression of Zika virus antigens illustrates a rapid method of antibody production against emerging pathogens.

31. Soluble expression of disulfide-bonded C-type lectin like domain of human CD93 in the cytoplasm of Escherichia coli.

32. The South Pacific epidemic strain of Zika virus replicates efficiently in human epithelial A549 cells leading to IFN-β production and apoptosis induction.

33. Recombinant human HSP60 produced in ClearColi™ BL21(DE3) does not activate the NFκB pathway.

34. Soluble HMGB1 is a novel adipokine stimulating IL-6 secretion through RAGE receptor in SW872 preadipocyte cell line: contribution to chronic inflammation in fat tissue.

Catalog

Books, media, physical & digital resources